Amgen (AMGN) Revenue — Quarter Ended Dec 31, 2023
Revenue increased compared with both the prior quarter and the same quarter a year earlier. The growth was driven by higher sales across key products.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue increased compared with both the prior quarter and the same quarter a year earlier. The growth was driven by higher sales across key products.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$8.2B
Revenue reported for this quarter.
Quarter-over-quarter
+18.7%
Change from the immediately preceding quarter.
Year-over-year
+19.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$28.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $6.1B | -2.1% |
| Jun 30, 2023 | $7B | +5.9% |
| Sep 30, 2023 | $6.9B | +3.8% |
| Dec 31, 2023 | $8.2B | +19.8% |
Revenue performance
The quarter's revenue rose from the preceding quarter, continuing an upward trajectory. The year-over-year comparison also showed a solid gain.
Quarterly comparison
Sequentially, revenue improved from the immediately preceding quarter. On an annual basis, revenue exceeded the level reported in the same quarter one year earlier.
What to watch
The quarter's revenue was the highest among the four most recent quarters.